Healthcare
The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials
Bayer, a global life sciences company, has announced a new strategic alliance focused on clinical trials collaboration with the University of Colorado Anschutz, UCHealth and Children's Hospital Colorado, establishing Bayer's first alliance of its kind with an academic medical center. The initiative reflects a shared commitment to accelerating clinical research through stronger collaboration between industry and academic medicine.
About this update from Bayer Ag
Bayer's first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies AURORA, Colo. and WHIPPANY, N.J., July 7, 2026 /PRNewswire/ -- Bayer , a global life sciences company, has announced a new strategic alliance focused on clinical trials collaboration with the University of Colorado Anschutz , UCHealth and Children's Hospital Colorado , establishing Bayer's first alliance of its kind with an academic medical center. The initiative reflects a shared commitment to accelerating clinical research through stronger collaboration between industry and academic medicine. The alliance is intended to improve clinical trial efficiency, expand patient access to investigational therapies, and advance new medical discoveries. Initial focus areas for the alliance will include research studies in oncology, cardiovascular disease, chronic kidney disease, neurodegenerative disease, cell and gene therapy, women's health, and ophthalmology. The alliance is designed to: Advancing Clinical Trials Through Collaboration The alliance will support innovative approaches to clinical trial design and implementation, enhanced patient enrollment, and expanded research operations. By combining Bayer's drug development expertise with the extensive academic and clinical strengths of the University of Colorado Anschutz (CU Anschutz), UCHealth and Children's Hospital Colorado (Children's Colorado), the collaboration aims to expedite clinical research and bring lifesaving experimental therapies to more patients. "Bayer is committed to bringing first-in-class or best-in-class therapies to market for the people who need them," said Christoph Koenen, Head, Clinical Development & Operations for Bayer. "Our alliance with this renowned academic medical center brings together several leading organizations to deliver new, innovative ways to advance clinical research for the benefit of patients." The alliance will also support clinical trial infrastructure while facilitating scientific collaboration to advance new therapies and medical innovations. Examples include: